Company Updates
With the launch of the Nox A1s, a full in-lab PSG with ambulatory capabilities, we can bring many of the complex channels typically reserved for the sleep laboratory into the bedroom of each person who needs a sleep test.
Company Updates
Nox Health, the global sleep health leader and parent company of Nox Medical, announced today a strategic growth investment from Vestar Capital Partners, a leading middle-market private equity firm in the United States. The investment will help Nox accelerate development…
Company Updates
Nox Medical has released the Nox A1s PSG system which features hospital-to-home flexibility and product enhancements to its predecessor, Nox A1.
Company Updates
Nox Medical has received the Innovation Excellence Award during the inaugural European Master of Excellence Awards held at the MasterControl Annual Masters Conference
Company Updates
Nox Medical has been recognized as a Model Firm for the Company of the Year 2021 awards in Iceland, a recognition that is assigned to companies that are considered to excel in creating a good working environment. Nox Medical is…
Company Updates
The Nox T3s is a customizable home sleep apnea test system that is both easy to use, cost-effective and provides accurate results meeting Type III criteria for sleep diagnostic devices.
Company Updates
Company Updates
We are honored to see Nox Medical listed among the top 2% of all companies in Iceland when it comes to financial fitness.
Company Updates
Nox Medical has revolutionized home sleep testing with the launch of its newest device, the Nox T3s. The Nox T3s is based on the world-renowned Nox T3, which launched in 2009 and quickly became, for many, the standard for home sleep testing.
